Yes, we at Canadians for Fair Access to Medical Marijuana were consulted by Finance. We also reached out to members across all parties, to senators, as well as to different bureaucrats in different departments.
With that said, I think the consultation was not as effective as we would like to have seen, in the sense that the submissions that were made overwhelmingly—the vast majority, from our understanding—in support of eliminating tax on medical cannabis.
As I mentioned, a coalition of very large, credible, respectable organizations—including the Arthritis Society, the Canadian Pharmacists Association, and the Canadian Nurses Association—has put forward a submission as part of that consultation process, but we don't feel that the government is adequately listening.
There was a small step to exempt low-THC oils, but that is a tiny percentage of the market. It shows a complete misunderstanding of what patients are using it for, and beyond that, it's not a decision that's based in evidence. The evidence, as James mentioned, is very strong and conclusive for the treatment of chronic pain in adults, MS spasticity, and nausea and vomiting induced by chemotherapy. That's for THC, and that is subject to excise tax.